Northwestern’s Brain Tumor SPORE — part of the Lurie Cancer Center — is now three years old, and the bench to bedside process is producing results.
Dozens of new PhD students from across the country and around the world have arrived on campus to begin their graduate programs at Northwestern University Feinberg School of Medicine.
D. James Surmeier, PhD, the chair and Nathan Smith Davis Professor of Neuroscience, has been named the winner of the 2021 Tripartite Legacy Faculty Prize in Translational Science and Education.
Blocking an inhibitory pathway within a subset of specialized T-cells may improve overall immune response against virally driven cancers, according to findings published in Nature.
Many cancers produce an enzyme called IDO that suppresses immune system activity, but the long-held hypothesis of how this mechanism operates requires revision, according to a Northwestern Medicine study.
A salt substitute with less sodium reduced rates of stroke and heart attack in rural China, according to a recent trial.
Harmful side effects from a common chemotherapy drug could be prevented in patients with a specific mutation by targeting retinoic acid receptors, according to a recent study.
Northwestern Medicine is part of the research team on a $185 million NIH project that will explore the millions of genetic variants that cause disease around the world.
Northwestern Medicine scientists have characterized several variants of the gene GRIK2 that cause nonsyndromic neurodevelopmental disorder.
Circulating tumor cells use the surface protein ICAM1 to strengthen stem cell programs and facilitate formation of tumor cell clusters, which can travel from primary tumors to other organs in the body.